ADC Therapeutics S.A. (NYSE:ADCT) Q3 2025 Earnings Call Transcript

ADC Therapeutics S.A. (NYSE:ADCT) Q3 2025 Earnings Call Transcript November 10, 2025

ADC Therapeutics S.A. beats earnings expectations. Reported EPS is $-0.30023, expectations were $-0.4.

Operator: Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics Q3 2025 Earnings Conference Call. At this time, lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call, you require assistance, please press 0...